Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-15 Purchase | 2022-11-17 7:10 pm | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 5,000 | $3.2884 | $16,442 | 65,836 (Direct) | View |
| 2022-06-28 Purchase | 2022-06-30 5:00 pm | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 10,000 | $2.88 | $28,800 | 52,955 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-04 Option Award | 2024-01-08 4:45 pm | N/A N/A | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 10,000 | $0 | 91,482 (Direct) | View |
| 2023-05-18 Option Award | 2023-06-06 7:35 pm | N/A N/A | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 7,764 | $2.41 | 81,482 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-06 7:35 pm | N/A 2029-08-14 | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 7,882 | $0 | 81,482 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-06 7:35 pm | N/A N/A | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 7,882 | $1.35 | 81,482 (Direct) | View |
| 2023-01-19 Option Award | 2023-01-23 5:53 pm | N/A 2033-01-18 | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-10-13 Exercise | 2022-10-17 6:06 pm | N/A 2029-08-14 | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 7,881 | $0 | 68,718 (Direct) | View |
| 2022-10-13 Exercise | 2022-10-17 6:06 pm | N/A N/A | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 7,881 | $1.35 | 68,718 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 7:54 pm | N/A N/A | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 10,000 | $0 | 42,955 (Direct) | View |
| 2022-05-18 Option Award | 2022-06-24 7:54 pm | N/A N/A | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 1,699 | $7.06 | 42,955 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:25 pm | N/A 2032-01-17 | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 180,000 | $0 | 211,256 (Direct) | View |
| 2021-11-18 Option Award | 2022-01-20 5:25 pm | N/A N/A | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 829 | $12.51 | 211,256 (Direct) | View |
| 2021-05-18 Option Award | 2021-07-21 4:47 pm | N/A N/A | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 2,055 | $14.45 | 46,190 (Direct) | View |
| 2021-07-21 Exercise | 2021-07-21 4:47 pm | N/A 2029-06-25 | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 28,372 | $0 | 46,190 (Direct) | View |
| 2021-07-21 Exercise | 2021-07-21 4:47 pm | N/A N/A | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 28,372 | $1.35 | 46,190 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 5:39 pm | N/A 2031-02-17 | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 72,000 | $0 | 72,000 (Direct) | View |
Ownership | 2020-09-17 8:30 pm | N/A 2029-06-25 | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 0 | $0 | 189,150 (Direct) | View |